Influence of Diet on the Course of Inflammatory Bowel Disease
- 1.2k Downloads
While the importance of diet in the pathogenesis of inflammatory bowel disease (IBD) is generally recognized, influence of food on the course of IBD is little understood.
The purpose of this study was to assess the association between food intake and course of disease in patients with IBD.
We performed a cross-sectional study on 103 adult patients (50 with active disease and 53 in remission, divided by their calprotectin level), who completed a food frequency questionnaire on their intake of several foods over 1 year. Diet, as assessed using a 146-item self-administered food frequency questionnaire, was correlated with objective evidence of disease based on fecal calprotectin levels.
Legumes and potato were inversely associated with disease relapse (p value for trend 0.023) with patients in the highest quartile for legume and potato consumption carrying a 79% lower risk of active disease (adjusted OR 0.21, 95% CI 0.57–0.81). A positive association emerged between meat intake and disease relapse, the highest quartile for meat consumption coinciding with a higher risk of active disease (OR 3.61, 95% CI 1.15–11.38), though this was not significant in the adjusted analysis. No statistically significant associations were found between disease relapse and the intake of vegetables, cereals, dairy products, or fish.
Our results suggest a potentially protective role of legumes and potato and a detrimental influence of meat in maintaining clinical remission in IBD patients. These findings have important public health implications, but further interventional studies will be needed to demonstrate these associations.
KeywordsInflammatory bowel diseases Fecal calprotectin Diet Legume Meat
The authors acknowledge Fabio Canesso who provided his expertise and greatly helped the research and Renata d’Incà who authorized the access to patients and data. The authors would also like to acknowledge the contribution of the staff and participants of the EPIC-Norfolk Study. EPIC-Norfolk is supported by the Medical Research Council program Grants (G0401527, G1000143) and Cancer Research UK program Grant (C864/A8257).
Compliance with ethical standards
Conflict of interest
The authors whose names are listed certify that they have no conflict of interest.
- 1.Fauci A, Braunwald E, Kasper D, Hauser S, Longo D. Harrison’s principles of internal medicine. 2008. doi: 10.1036/007149619X.
- 2.Bernstein CN, Eliakim A, Fedail S, et al. Inflammatory bowel disease. World Gastroenterol Global Guidelines. 2015;50:803–818.Google Scholar
- 13.Cohen S, Gold BD, Oliva S, et al. Clinical and mucosal improvement with the specific carbohydrate diet in pediatric Crohn’s disease: a prospective pilot study. J Pediatr Gastroenterol Nutr. 2014;59:516–521.Google Scholar
- 15.Lev-Tzion R, Griffiths A, Leder O. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2014.Google Scholar
- 16.Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Inflamm Bowel Dis. 2004;54:1479–1484.Google Scholar
- 19.Zittan E, Kelly OB, Kirsch R, et al. Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn’s disease. Inflamm Bowel Dis. 2016;23:1–8.Google Scholar
- 22.Yamaguchi S, Takeuchi Y, Arai K, et al. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis. J Gastroenterol Hepatol. 2015;1:93–98.Google Scholar
- 25.Fantuzzi F, Chiunchiù M, Bedogni G. Atlante fotografico delle porzioni degli alimenti. Milano: Istituto Scotti Bassani; 2005.Google Scholar
- 30.Verspreet J, Damen B, Broekaert WF, Verbeke K, Delcour JA, Courtin CM. A critical look at prebiotics within the dietary fiber concept. Annu Rev Food Sci Technol. 2016;7:annurev-food-081315-032749.Google Scholar
- 39.Di Bartolomeo F, Startek JB, Van Den Ende W. Prebiotics to fight diseases: reality or fiction? Phyther Res. 2013;27:1457–1473.Google Scholar
- 53.Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2015;65:1–10.Google Scholar
- 58.Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;22:1.Google Scholar